At Johnson & Johnson,?we believe health is everything. Our strength in healthcare innovation empowers us to build a?world where complex diseases are prevented, treated, and cured,?where treatments are smarter and less invasive, and?solutions are personal.?Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.?Learn more at https://www.jnj.com
Job Function:
Market Access
Job Sub Function:
Health Economics Market Access
Job Category:
People Leader
All Job Posting Locations:
Raritan, New Jersey, United States of America
Job Description:
About Innovative Medicine
Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.
Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.
Learn more at https://www.jnj.com/innovative-medicine
The Senior Compound Market Access Leader (SCMAL) is a career pathway and talent advancement opportunity to lead the strategic planning and implementation of the payer value generation and access strategies for innovative medicines in early development to commercialization. The position resides in the Neuroscience Therapeutic Area of the Global Commercial Strategy Organization and reports to VP of Market Access for Neuroscience. For the assigned therapeutic area, the SCMAL serves as the leading resource on access strategies and is an active member of the global clinical and commercial product teams, as well as the disease area strategy teams. They will be responsible for integrating pricing, market and payer research, health economics and epidemiology information to develop the optimal global value strategy. The SCMAL will be responsible for the following activities in their disease area:
Market Access Strategy:
Leads the Compound Market Access Team (CMAT) across parallel indications, which includes the core functions within Global Market Access (i.e., Health Economics, Patient Reported Outcomes [PRO], Access Policy, Pricing, Real-World Evidence & Analytics) to deliver the global market access strategy & key value communication tools for the brand.
Design, develop and implement an integrated approach to all aspects of the payer value proposition from early development through and beyond loss of exclusivity for a complex portfolio of compounds and indications.
Responsible for the strategic planning and implementation of the payer value generation and access strategies.
Serve as the leading resource on access strategies and is an active member of the global clinical and commercial product teams, as well as the disease area strategy teams
Responsible for integrating pricing, payer research, health economic and epidemiology information to develop the optimal value strategy.
Interact with Regional Market Access/Health Economics / Outcomes Research/Scientific Affairs and Medical Affairs teams to coordinate and develop real world evidence generation in support of their access programs.
Develop an integrated access strategy that reflects macro (health care reform, quality metrics, technology assessment) and disease specific (clinical profile, market segmentation, disease staging and clinical pathway) factors as well as the complexity of a companion diagnostic.
Be responsible for ensuring that clinical development programs fully capture the value of innovative products to payers, physicians and patients. This includes strategic advice to teams on patient populations, trial design, selection of relevant endpoints as well as ensuring quality implementation of study protocols, case report forms, monitoring protocols, statistical analyses plans, etc.
Drive the design and management of health outcomes studies including: systematic literature reviews, Real World Evidence studies, and user-friendly cost effectiveness and budget impact models.
Be responsible for educating the commercial and R&D teams on key access trends and opportunities to shape their evolution.
Provide leadership to the Clinical Development Team (CDT) in terms of market access data needs related to the clinical development plan; represent the access needs of the regions as a subject matter expert and advocate for the data necessary for positive reimbursement across the global markets.
Take budgetary responsibility for defining and managing the market access discretionary budgets, ensuring that spending is managed effectively throughout the year and to plan.
Develop deep expertise of the clinical and market access drivers unique to neuropsychiatry to drive the debate externally to influence market access and reimbursement approaches to these novel therapies.
Keep up to date with scientific developments, bringing the latest techniques and analyses to build the strongest possible value proposition.
Understand the patient perspective of the disease and recommend strategies that can support the patient voice in key payer negotiations.
Team Leadership:
Lead a team including Compound Market Access Leaders (CMALs) and/or Associate CMALs.
Develop, coach and train team members on own team as well as within broader MA organization.
Recruit and build pipeline for the team.
Strategic alignment across Regions and Countries:
Lead or guide CMALs to lead an engaged and collaborative Extended Market Access team, ensuring great communication and collaboration, sharing of best practice and co-creation.
To enable timely reimbursement and patient access, proactively support engagements with key external decision makers to reach a consensus on acceptable evidentiary requirements.
Partner on the design of payer research and provide support for early scientific advice.
Work with pricing colleagues to provide expert perspectives and establish pricing policies.
Oversee the evaluation and modelling of innovative pricing and contracting initiatives and support execution.
Foster collaboration, alignment and seamless working across R&D and GCSO functions, including the Clinical Development Team (CDT), Commercial, Medical Affairs, and Global Market Access COE to ensure optimal launch readiness for the brand.
Required Education & Experience:
Master's Degree or above in a relevant field
Minimum of 10 years of professional experience in the pharmaceutical industry (global, regional or operating company level) with a focus in Epidemiology, Health Economics, Payer Access.
8 years of experience managing teams with direct reports and projects.
Having experience in access and payer negotiation the US and/or EMEA markets
Required Skills:
Market Access Landscape: The ability to shape the evolving payer landscape by researching, developing, and maintaining a deep understanding of payers and their perspectives in the key global markets including US and EMEA regions. This includes knowledge of trends in pricing, reimbursement, healthcare policy, and all market arche@types.
Healthcare Ecosystem: Knowledge of and ability to assess and navigate the evolving external healthcare environment such as the ones in the US and EMEA to create policy strategies for product or disease area and influence policymaking institutions. This includes an understanding of global healthcare systems and policies and how they impact local and regional efforts.
Health Technology Assessment: Knowledge of the principles of evidence-based medicine and methodologies to evaluate health-related technology and deliver product dossiers.
Market Access Analytics: The ability to systematically gather and analyze information from various sources, including modeling, pricing, and contracting strategies. This includes the ability to generate data to support real-world evidence, identify and communicate patterns and trends, and evaluate and develop strategic plans.
Evidence Generation: The ability to apply data science concepts and methodologies to identify and articulate value propositions, create and implement value strategies, generate business insights, and drive evidence generation and debate on the appropriateness of conclusions. This includes providing market access inputs to clinical trial design, implementation, and analyses and knowledge of meta-analysis as well as epidemiologic studies.
Clinical Trial Methodology: Knowledge of clinical trials and trial design. This includes applying knowledge to recommend study design plan and methodology, considering trade-offs of different approaches, and developing hypotheses to test primary versus secondary endpoints and implications for labeling.
Strong written and oral communication skills
Preferred Education & Experience:
Ph.D., Pharm D, MD, or M.Sc. in appropriate field (preferably Epidemiology, Health Economics, Public Health, Health Policy).
Experience in multiple therapy areas.
Demonstrated leadership ability to successfully work across functional and geographic boundaries, preferably across multiple countries/market @types/access models.
Johnson & Johnson is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, disability, protected veteran status or other characteristics protected by federal, state or local law. We actively seek qualified candidates who are protected veterans and individuals with disabilities as defined under VEVRAA and Section 503 of the Rehabilitation Act.
Johnson and Johnson is committed to providing an interview process that is inclusive of our applicants' needs. If you are an individual with a disability and would like to request an accommodation, please email the Employee Health Support Center (ra-employeehealthsup@its.jnj.com) or contact AskGS to be directed to your accommodation resource.
The anticipated base pay range for this position is :
178 986 - 309 254
Additional Description for Pay Transparency:
